Search

everythinglearnresearchcommunity

for

Search:↓

mTOR signaling helps activate hair stem cells by balancing out the suppression caused by BMP during hair growth.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Fibroblasts can be turned into melanocytes for potential skin treatments.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Human hair follicle cells can be turned into stem cells similar to embryonic stem cells.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Keratins are important for skin cell health and their problems can cause diseases.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

HIV can cause unusual and severe skin problems that are hard to treat.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Tooth regeneration could become possible by controlling how and when bioactive factors are released.